Related Experiment Videos

Mycoplasma pneumoniae Infection in Children: Clinical Features and Outcomes

Roxana Taras1,2, Keon Theodore Nicolae3, Eliza Elena Cinteza1,4

  • 1Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Maedica
|July 8, 2026
PubMed
Abstract

Insights

Mycoplasma pneumoniae (MP) infections in children are linked to higher white blood cell counts and more severe outcomes. Elevated antibody titers and symptoms like fever predict longer hospital stays, aligning with global data.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Mycoplasma pneumoniae (MP) is a significant pathogen causing community-acquired respiratory infections, particularly in children and young adults.
  • MP infections exhibit cyclical outbreaks, necessitating ongoing epidemiological surveillance.

Purpose of the Study:

  • To analyze the clinical and epidemiological characteristics of pediatric MP infections in a tertiary hospital.
  • To identify prognostic markers associated with disease severity and hospitalization duration.

Main Methods:

  • Retrospective analysis of a pediatric patient cohort treated in Bucharest.
  • Comparison of findings with existing international literature on MP infections.

Main Results:

  • Elevated anti-MP antibody titers (IgG, IgA, IgM) correlated with leukocytosis, neutrophilia, complications, and prolonged hospitalization.
  • Fever, lobar pneumonia, and complications were independently associated with longer hospital stays.

Conclusions:

  • The study findings align with international data on the epidemiological profile of pediatric MP infections.
  • Results contribute to understanding MP infection post-COVID-19 and highlight the need for prospective studies to validate prognostic markers.
Keywords:
Mycoplasma pneumoniaechildrenpneumonia

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...